Application of humanized mice in the safety experiments of antibody drugs

QR Code

Application of humanized mice in the safety experiments of antibody drugs

Abstract Therapeutic antibodies are valued for their high specificity and selectivity in immunotherapy. However, the potential toxicity they may elicit underscores the necessity of assessing their preclinical efficacy and safety using suitable animal models. In this context, we review the various ca...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhimin Sun, Mengyun Gu, Zixuan Yang, Lei Shi, Liyuan Zhao, Minhui Zheng, Yan Wang, Wei Zhang, Kexin Han, Naping Tang
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Animal Models and Experimental Medicine
Subjects:	antibody drugs humanized mice immunogenicity preclinical evaluation
Online Access:	https://doi.org/10.1002/ame2.12562
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
by: Maria U. Johansson, et al.
Published: (2023-12-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

Antibody response in Hamsters Immunized against experimental Leishmaniasis
by: Baghdad Science Journal
Published: (2011-03-01)

Comparative Analysis of Ultrasonography and MicroCT Imaging for Organ Size Evaluation in Mice
by: Juan Jose Jimenez Catalan, et al.
Published: (2025-06-01)

SITA: Predicting site-specific immunogenicity for therapeutic antibodies
by: Yewei Cun, et al.
Published: (2025-06-01)

Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum
by: M. A. Kolganova, et al.
Published: (2023-05-01)

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
by: Marco Allinovi, et al.
Published: (2025-08-01)

Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01)

Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020-01-01)

Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice
by: O. S. Kashirina, et al.
Published: (2015-08-01)

Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
by: Yoshiyuki Arata, et al.
Published: (2023-12-01)

Immunological assessment and homogeneity of commercial inactivated bivalent Newcastle and avian influenza H9N2 vaccines in broilers
by: Zena T. Younis, et al.
Published: (2025-07-01)

COMPARISON OF COLORIMETRIC AND CHEMILUMINESCENT ELISA TESTS FOR DETECTION OF IgG ANTIBODIES TO HUMAN EPO IN THE SERA OF EXPERIMENTAL ANIMALS
by: A. M. Kudryashova, et al.
Published: (2018-12-01)

Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
by: Romain Ollier, et al.
Published: (2023-12-01)

Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma
by: A. N. Afanaseva, et al.
Published: (2024-03-01)

Preclinical in vivo Neurotoxicity Studies of Drug Candidates
by: N. V. Eremina, et al.
Published: (2020-09-01)

Development and Validation of the Cell-based Functional Method for Neutralizing Anti-adalimumab Antibodies Detection in Human Serum
by: M. A. Nikiforova, et al.
Published: (2024-03-01)

A Semi-Mechanistic Mathematical Model of Immune Tolerance Induction to Support Preclinical Studies of Human Monoclonal Antibodies in Rats
by: Paridhi Gupta, et al.
Published: (2025-06-01)

Evaluation the effect of Retin - A on some internal organs and skin in pregnant white mice Mus musculus and embryos
by: Zeena Ibrahim Khalil Ibrahim Al-Medalal, et al.
Published: (2023-02-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
by: Cynthia Burman, et al.
Published: (2024-12-01)

Study the effect of Atenolol drug in kidneys of Adult Swiss white mice
by: Nada Aziz Khalid, et al.
Published: (2023-01-01)

Methods of creation of bladder cancer models and their application in preclinical studies (literature review)
by: I. A. Kamaeva, et al.
Published: (2022-05-01)

Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer
by: Yu. V. Medvedev, et al.
Published: (2020-05-01)

Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem
by: T. V. Korotaeva
Published: (2016-01-01)

Implications of Anaphylaxis Following mRNA-LNP Vaccines: It Is Urgent to Eliminate PEG and Find Alternatives
by: Jinxing Song, et al.
Published: (2025-06-01)

The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients
by: Mateusz Makuch, et al.
Published: (2025-07-01)

Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study
by: Xiang Guo, et al.
Published: (2024-12-01)

Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses
by: K. V. Sivak, et al.
Published: (2024-12-01)

Learning genetics with mice
by: Wallace, Margaret Elise
Published: (1971)

DEVELOPMENT AND VALIDATION OF A METHOD FOR DETERMINING NEUTRALIZING ANTIBODIES TO PEMBROLIZUMAB IN HUMAN SERUM BASED ON INHIBITION OF BINDING OF PEMBROLIZUMAB TO ITS PD-1 TARGET BY ELISA
by: A. M. Kudryashova, et al.
Published: (2019-08-01)

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01)

Preclinical studies of Russian biological drugs based on technologically processed antibodies: review of foreign publications
by: N. F. Bunkin, et al.
Published: (2023-11-01)

Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum
by: O. A. Eliseeva, et al.
Published: (2022-12-01)

RESULTS OF PRECLINICAL SAFETY TESTING COMPARISON FOR IBUPROFEN DRUG PRODUCTS
by: E. A. Sitnikova, et al.
Published: (2019-01-01)

Immune Response Induced by Immunisation with Antiviral Vaccines
by: N. A. Alpatova, et al.
Published: (2020-03-01)

Vaccine-induced responses to R21/Matrix-M – an analysis of samples from a phase 1b age de-escalation, dose-escalation trial
by: Caroline Bundi, et al.
Published: (2025-06-01)

Embryological developmental changes in the gonads of male mice associated with lead administration
by: Ibtisam J. Sodani, et al.
Published: (2024-10-01)

Advancements in antibody-drug conjugates as cancer therapeutics
by: Jung Yin Fong, et al.
Published: (2025-08-01)

Morphological and Histological Changes in Liver and Lung of mice and Their Embryos Administred with Parkizol Drug
by: Hafidh Ibrahim Al-Sadi, et al.
Published: (2023-02-01)

Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines
by: L. M. Khantimirova, et al.
Published: (2016-02-01)